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When inhaled, ozone (O3) interacts with cholesterols of air-
way epithelial cell membranes or the lung-lining fluid, generat-
ing chemically reactive oxysterols. The mechanism by which
O3-derived oxysterols affect molecular function is unknown.
Our data show that in vitro exposure of human bronchial epi-
thelial cells to O3 results in the formation of oxysterols, epoxy-
cholesterol- and - and secosterolAandB (SecoAandSecoB),
in cell lysates and apical washes. Similarly, bronchoalveolar
lavage fluid obtained from human volunteers exposed to O3
contained elevated levels of these oxysterol species.As expected,
O3-derived oxysterols have a pro-inflammatory effect and
increase NF-B activity. Interestingly, expression of the choles-
terol efflux pumpATP-binding cassette transporter 1 (ABCA1),
which is regulated by activation of the liver X receptor (LXR),
was suppressed in epithelial cells exposed to O3. Additionally,
exposure of LXRknock-outmice toO3 enhancedpro-inflamma-
tory cytokine production in the lung, suggesting LXR inhibits
O3-induced inflammation. Using alkynyl surrogates of O3-de-
rived oxysterols, our data demonstrate adduction of LXR with
Seco A. Similarly, supplementation of epithelial cells with alky-
nyl-tagged cholesterol followed by O3 exposure causes observ-
able lipid-LXRadduct formation. Experiments using SecoAand
the LXR agonist T0901317 (T09) showed reduced expression of
ABCA1 as compared with stimulation with T0901317 alone,
indicating that Seco A-LXR protein adduct formation inhibits
LXR activation by traditional agonists. Overall, these data
demonstrate that O3-derived oxysterols have pro-inflammatory
functions and form lipid-protein adducts with LXR, thus lead-
ing to suppressed cholesterol regulatory gene expression and
providing a biochemical mechanism mediating O3-derived for-
mation of oxidized lipids in the airways and subsequent adverse
health effects.
Currently, the oxidant gas ozone (O3) is themost widespread
air pollutant found in the United States and contributes to a
growing variety of adverse health outcomes (1). O3 exposure
causes decreased lung function and increased airway inflamma-
tion, which exacerbates pre-existing diseases such as asthma
and may contribute to certain cardiovascular diseases, all
potentially increasing the risk of premature death (2). Although
the inflammatory response and adverse health effects of O3
exposure have been documented for decades, the biochemical
and cellular mechanisms by which O3 mediates adverse health
effects remain poorly understood. As a very potent oxidant gas,
O3 reacts readilywith the surface components of the airway and
causes cellular modification through reactions with the airway-
lining fluid and epithelial cellular membranes (2–4). The lung-
lining fluid and epithelial cellmembranes are rich in cholesterol
and other lipids, which can be directly oxidized by O3 (5, 6).
Previous studies have determined the impact that ozonization
of lipids, particularly polyunsaturated fatty acids (PUFA), may
have on O3-associated toxic effects. These studies demon-
strated that ozonization of PUFAs and the formation of lipid
ozonization products can mimic many of the adverse health
effects observed after exposure to O3 (5, 7–9). However, the
involvement of cholesterol ozonization products requires fur-
ther study. The cholesterol 5,6-double bond and concomitant
vinylicmethylene groupmoieties are particularly susceptible to
oxidation, resulting in the formation of oxysterols (5, 10–12).
Many oxysterols are electrophiles capable of reacting
with nucleophilic residues on proteins and other biological
macromolecules. They are formed endogenously through enzy-
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matic and non-enzymatic reactions. P450 cytochrome enzymes
metabolize endogenous cholesterol into oxysterol species such
as 27-hydroxycholesterol, an essential oxysterol for cellular
cholesterol homeostasis (13). Studies show that endogenous
oxysterols can act as both agonists and antagonists for tran-
scription factors such as the liver X receptor (LXR).2Within the
LXR protein, a ligand binding domain has been characterized
and shown to bind to synthesized oxysterol species in vitro,
which is the same region that is the target for various post-
translational modifications such as acetylation and SUMOyla-
tion (14). LXR regulates the synthesis of cholesterol trans-
port proteins, such as ATP-binding cassette transporter A1
(ABCA1). ABCA1 transports cholesterol across the cell mem-
brane and shuttles it onto apolipoproteins, resulting in the for-
mation of high density lipoproteins (HDL). Systemically, failure
to produce adequateABCA1 reduces the ability to generate and
transportHDLand is associatedwith early onset cardiovascular
disease, supporting the protective role of ABCA1 in cholesterol
metabolismand atherosclerosis (15). In addition to lipidmetab-
olism, both LXR and ABCA1 have been implicated in anti-in-
flammatory functions (16–19).Moreover, exogenously derived
oxysterols can cause adverse cellular effects and have been
shown to modulate host immune cell and inflammatory
responses (20–22). Oxidation of endogenous cholesterols by
various reactive oxygen species results in the formation of oxy-
sterols associated with various pathological processes driven by
interaction with the nucleophilic domains of key proteins (23).
Elevated levels of specific oxysterol species have been linked to
a variety of adverse biological activities, including cytotoxicity,
increased inflammation, and amplified infection (24–26).
Rodent exposure studies and in vitro studies using human
pulmonary surfactant have demonstrated the formation of
O3-derived oxidized cholesterol products in various chemical
compositions (5, 6, 10, 27, 28). Fig. 1 depicts the primary reac-
tive O3-derived oxysterol products secosterol A (Seco A) along
with its aldol condensation product secosterol B (Seco B), and
epoxycholesterols  and  (-EpCh and -EpCh) (11, 29).
Some of these O3-derived oxysterols have been found in ath-
erosclerotic tissue and cause foam cell formation, a hallmark of
plaque buildup (26). Despite increased interest in the role of
oxysterols in human health, especially cardiovascular diseases,
information about O3-derived oxysterols in the airway, their
cellular targets, and their biochemical interactions is very
limited.
We hypothesize that exposure to O3 generates lipid-derived
electrophiles in the human airway, including reactive species of
oxysterols, at or near the epithelial surface that can adduct to
cellular proteins, thus ultimately affecting cellular function and
inflammatory response. Our study is designed to uncover elec-
trophilic interactions between O3-derived oxysterols and pro-
teins as a new mechanistic paradigm mediating adverse health
effects induced upon inhalation of O3.
Results
Identification of O3-induced Oxysterol Formation in Vitro
and in Vivo—Primary differentiated HBEC cells and 16HBE
cells were chosen to evaluate the presence of oxysterol species
in vitro following exposure to O3. Representative HPLC-MS
profiles reflected increased levels of oxysterol species in O3-ex-
posed 16HBE cells (Fig. 2A) comparedwith filtered air-exposed
cells. 16HBE cells exposed to O3 exhibited elevated concentra-
tions of-EpCh,-EpCh, and SecoB in cell lysates (Fig. 2B) and
in the apical washes (Fig. 2C) collected both 1 and 24 h post-
exposure compared with the air-exposed control. A similar
trend was observed in primary HBEC lysates (Fig. 2D) and api-
cal washes (Fig. 2E) at both 1 and 24 h post-exposure compared
with air-exposed controls. Overall, the cholesterol concentra-
tion did not significantly change due to O3 exposure or sample
collection time in either 16HBE (4870  597 ng/sample air to
5168  138 ng/sample O3) or primary HBE (50121  1554
ng/sample air to 5506 772 ng/sample O3) cells.
To test the formation of O3-derived oxysterols in humans in
vivo, we determined the levels of oxysterols identified in BALF
obtained from healthy volunteers exposed to filtered air or 0.3
ppm O3 for 2 h. The BALF was collected by bronchoscopy at 1
and 24 h post-exposure, and various oxysterol species were
2 The abbreviations used are: LXR, liver X receptor; -EpCh and -EpCh,
epoxycholesterol- and -; BisTris, 2-[bis(2-hydroxyethyl)amino]-2-(hy-
droxymethyl)propane-1,3-diol; qPCR, quantitativePCR;ANOVA, analysis of
variance; LXRE, LXR response element; BALF, bronchoalveolar lavage fluid;
HBEC, human bronchial epithelial cell; PPAR, peroxisome proliferator-acti-
vated receptor; HBBS, Hanks’ balanced salt solution; EPA, Environmental
Protection Agency; Seco, secosterol; BHT, butylated hydroxytoluene; TPP,
triphenylphosphine;T09,T0901317;a-Chol, alkynyl-taggedcholesterol;qPCR,
quantitativePCR;a-Seco,alkynyl-Seco;AMBIC,ammoniumbicarbonate;MEM,
minimal essential medium; FAM, 6-carboxyfluorescein; TAMRA, 6-carboxy-
N,N,N,N-tetramethylrhodamine; 7-DHC, d7-7-dehydroxycholesterol.
FIGURE 1. Cholesterol and themajor oxysterols formed in the reaction with ozone.
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quantified by HPLC-MS. Exposure to O3 significantly elevated
the concentrations of -EpCh (Fig. 3B) and Seco A (Fig. 3C)
comparedwith individuals exposed to filtered air controls at 1 h
post-exposure with p values of less than 0.001 and 0.05 respec-
tively. Amoderately convincing increase (p 0.1)was observed
for -EpCh (Fig. 3A) and no difference in Seco B (Fig. 3D).
FIGURE 2.Oxysterol concentrationsmeasured in cells and apical washes exposed to filtered air or O3 and their HPLC-MS profiles. All cells were grown
in 24-mm Transwell membrane plate until confluency followed by removal of the apical medium and exposure to filtered air or 0.4 ppmO3 for 4 h. Cell lysates
and apical washes were collected at 1 and 24 h post-exposure. A, representative reverse phase-HPLC-multiple reactionmonitoring chromatograms of epithe-
lial cells exposed toair or 0.4ppmozone.MS for eachpanel is selected reactionmonitoringof them/z indicated in theair exposure.B,16HBEcell lysate.C,16HBE
apical wash. D, primary HBEC cell lysate. E, primary HBEC apical wash. Data are presented as means S.E. Statistical analysis was performed with a one-way
ANOVA and Fisher’s LSD post hoc test comparing observed means against the respective air-exposed control. *, p 0.05. n 3.
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Unlike the results observed in the in vitro samples, we observed
that oxysterol concentrations returned to baseline levels 24 h
post-exposure. Again, therewas no significant change in overall
BALF cholesterol concentration in subjects exposed to air
(6639 1556 ng/ml) compared with O3 (6698 2245 ng/ml).
Effects of O3 on Cholesterol Efflux and Cytokine Gene Ex-
pression—As expected and previously described by us (30, 31),
exposure to O3 caused an inflammatory response as marked
by increased gene expression (Fig. 4, A and B) and protein con-
centration (Fig. 4, C and D) of pro-inflammatory cytokines IL6
and IL8. Treatment with synthetic LXR agonist T0901317
(T09) alone did not affect the levels of IL6 or IL8 expression
(Fig. 4,A andB). Interestingly, exposure toO3 in the presence of
T09 significantly decreased the expression of cholesterol efflux
pump proteins ABCG1 (Fig. 4E) and ABCA1 (Fig. 4F), suggest-
ing O3-induced inhibition of the LXR pathway. Additionally,
ABCA1 protein levels were significantly reduced in cells
exposed to O3 compared with air as shown in relative densi-
tometry from three separate experiments (Fig. 4G) and repre-
sentative immunoblot (Fig. 4H).
LXR-/Mice Are More Susceptible to O3-induced Inflam-
mation—Female LXR/ were compared with WT mice.
Eachwere exposed to filtered air or 2 ppmO3 for 3 h. BALFwas
collected from both conditions and evaluated for concentra-
tions of IL6. The LXR-/ mice showed significantly higher
concentrations of IL6 compared with the WT (Fig. 5A). At
necropsy, the lungs were removed and homogenized for RNA
isolation and qPCR analysis. In a similar result, IL6 mRNA lev-
els were significantly higher in the LXR-/mice exposed to
O3 compared with the WT control mice exposed to O3 (Fig.
5B). As seen in the human BALF samples (Fig. 3, C and D),
exposure to O3 increases the amount of Seco A (Fig. 5C) and
SecoB (Fig. 5D) in themouse BALF samples with significantly
higher amounts of Seco A present in the LXR-/ com-
pared with the WT mice. Interestingly, unlike the human
samples, total cholesterol levels decreases in O3-exposed
animals (Fig. 5E).
Exposure to a-Seco A Reveals LXR- Protein Adducts—Based
on recent studies demonstrating oxysterol-induced lipid-pro-
tein adducts, we hypothesized that O3-derived oxysterols can
adduct to the LXR- and LXR- proteins, which contain reac-
tive lysine residues (14, 29). Seco A, a primary ozonide and one
of themost reactive O3-derived oxysterols, reacts with proteins
and causes covalent modifications leading to lipid-protein
adduct formation (32). 16HBE cells were treated with alkynyl-
tagged SecoA (a-SecoA), and the adducted proteinswere iden-
tified by first adding biotin to the alkynyl tag utilizing click
cyclo-addition (Fig. 6A) followed by immunoaffinity purifica-
tion with streptavidin beads and photo-release (Fig. 6B), which
frees cellular proteins adducted by a-Seco A. This mixture of
proteins was subsequently subjected to Western blotting anal-
yses using antibodies against HSP90, LXR-, LXR-, PPAR-,
and -actin (Fig. 6C). HSP90 was used as a positive control
based on previous studies (33). Our data show that treatment of
bronchial epithelial cells with a-Seco A results in the formation
of Seco A-LXR adducts.
Alkynyl Cholesterol-supplementedCells Exposed toO3 Reveal
the Formation of LXR- Adducts—16HBE cells were supple-
mented with 20 M alkynyl-tagged cholesterol (a-Chol) for 6
days. Media containing a-Chol changed daily with washes on
the apical side 24 h prior to exposure (Fig. 7B). The 16HBE cells
were exposed to filtered air or 0.4 ppmO3 for 4 h and harvested
1 h post-exposure. Our data show that a-Chol, a surrogate of
endogenous cholesterol, is incorporated into the cells and, in
response to O3, generates a host of alkynyl-oxysterols identical
to the oxysterol species generated via oxidation of endogenous
cholesterol (Fig. 7A). Based on streptavidin analysis, cells
exposed toO3 exhibit a higher overall level of protein adduction
with oxidized cholesterol species than cells exposed to air (Fig.
7C). Similar to cells treated with a-Seco A, HSP90 and LXR-
FIGURE3.Oxysterol concentrationsmeasured inairwayBALF.Healthy individualswere exposed to either filtered air (control) or 0.3 ppmO3 for 2h. Cell-free
BALF was collected by bronchoscopy at 1 and 24 h post-exposure. Oxysterols were quantified by HPLC-MS spectrometry. A, -EpCh. B, -EpCh. C, Seco A. D,
Seco B. Data are presented asmeans S.E. Statistical analysis was performedwith paired Student’s t test (two-tailed distribution, pairing based on subject). *,
p 0.05; **, p 0.001. n 9–11.
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were found to be targets of alkynyl-tagged oxysterols generated
endogenously in cells exposed to O3 (Fig. 7D). The broad band
of LXR antibody-reactive proteins shown in Fig. 7D (EluteO3)
suggests that a set of O3-derived adducts are formed under
conditions of endogenous oxysterol genesis. This is in contrast
to the homogeneous protein adduct observed after exposure to
a single exogenous electrophile, as shown in Fig. 6C for the
experiment with a-Seco A. Fig. 7E shows the densitometric
analysis of O3-derived adducts of LXR- from three separate
experiments.
Oxysterol Exposure Alters ABCA1, FASN, and SREBP1 Gene
Transcription—Considering the effects of oxysterols on adduct
formation with LXR, we evaluated whether exposure to oxyste-
rols can alter expression levels of genes controlling cholesterol
biosynthesis, fatty acid synthesis, and cholesterol efflux in
16HBEcells. Todeterminewhether oxysterol adduct formation
with LXR inhibits subsequent activation of LXR, we sequen-
tially treated 16HBE cells with DMSO, Seco A, or T09 for 2 h,
removed the first treatment, and followed with a second chal-
lenge for 2 h (Fig. 8A). Treatment with Seco A followed by T09
significantly suppressed ABCA1 (Fig. 8B), FASN (Fig. 8C), and
SREBP1 (Fig. 8D) gene expression compared with cells exposed
toDMSO followed by T09 andT09 followed by T09, suggesting
that initial treatment with Seco A reduces the ability of T09 to
enhance cholesterol synthesis and efflux gene expression. Chal-
lenge with individual oxysterol species yielded no significant
change in LXRE activity when compared with the DMSO vehi-
cle control (Fig. 8E). However, LXRE activity was significantly
reduced in cells sequentially treated with Seco A followed by
T09 compared with cells sequentially treated with DMSO fol-
lowed byT09 or T09 followed byT09 (Fig. 8F), again suggesting
that initial treatment with Seco A reduces the ability of T09 to
activate LXR.
Exposure to Individual Oxysterols Activates the Inflamma-
tory Gene Transcription Pathway—To determine whether
O3-derived oxysterols modify expression of inflammatory
genes alone and in relation to known agonists, 16HBE cellswere
sequentially treated with DMSO, Seco A, or T09 for 2 h fol-
lowed by a second challenge for 2 h as described above (Fig. 8A).
Exposure to SecoA followed byT09 increased the expression of
IL6 (Fig. 9A) and IL8 (Fig. 9B) compared with the DMSO-
treated control. Additionally, individual O3-derived oxysterol
FIGURE4.Cholesterol effluxpumpprotein andpro-inflammatory cytokinegeneexpression levels in 16HBE cells.Cellswere exposed to filtered air or 0.4
ppm ozone for 4 h with and without 10M T09. RNA and apical wash samples were collected 1 h post-exposure and analyzed. Inflammatory gene expression
levels IL6 (A), IL8 (B), and protein levels IL6 (C) and IL8 (D) as well as gene expression levels for ABCG1 (E) and ABCA1 (F) were measured. Additionally, ABCA1
protein levelswere evaluatedby immunoblot (G) and relative densitometry (H) from three separate experiments. Data are presented asmeans S.E. Statistical
analysis was performed with a one-way ANOVA and Fisher’s LSD post hoc test comparing observed means against the respective treatment/air-exposed
control, *, p 0.05, or against the DMSO/air-exposed vehicle control, #, p 0.05, n 3.
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species significantly increased the NF-B activity compared
with the DMSO control (Fig. 9C), suggesting that O3-derived
oxysterols enhance pro-inflammatory pathways.
Discussion
Despite a large body of research on O3-induced toxicity and
adverse health effects, the biochemical and cellular signaling
cascades induced by O3 exposure in the human airways are not
fully understood. O3 is a known oxidant of themacromolecules
in the airway-lining fluid, and the formation of many oxidized
lipid products has been previously described along with their
biochemical effects. For example, instillation of 5,6-epoxy-
cholesterol (-EpCh) and 1-palmitoyl-2-(9-oxo-nonanoyl)-
glycerophosphocholine, which are both formed during O3
exposure, causes neutrophilic influx, which in turn was regu-
lated by class A scavenger receptors, known to bind oxidized
lipids (3). Ozonization of phospholipids generates products
with strong pro-inflammatory effects (8, 9). Additionally, O3 is
known to react with lung surfactant proteins, modifying and
inhibiting their normal biological functions (34–36). O3-in-
duced oxidized cholesterol products, however, have only par-
tially been described in their effects on the biological properties
of the human airway. Through this study, our results address
the knowledge gap between O3-induced cholesterol oxidation
in the airway and downstream cellular signaling events. Our
data demonstrate that O3-derived oxysterols can form lipid-
protein adducts with cellular signaling molecules, revealing a
new paradigm that lipid-protein adduct formation provides a
central mechanism for O3-derived oxidized lipids to modify
cellular responses.
Lipid protein adduction as a means to alter normal signaling
has been shown to occur during exposure to other oxidative
stressors, including the free radical-induced formation of 4-hy-
droxynoneal (37, 38). Although formation of oxysterols follow-
ing exposure toO3 has been shown before (28, 35), whether and
how these O3-derived oxysterols can form oxysterol-protein
adducts in the context of O3 exposure in the human airway has
not been examined. Assays based on “click” cyclo-addition
methods make it possible to visualize protein-lipid adducts via
immunostaining and to determine protein adductions with
specific signaling molecules, thus providing novel insight into
themechanisms behindO3-induced adverse health effects (39).
Using this approach, our results demonstrate the formation of
oxysterol-protein adducts in airway epithelial cells as a result of
exposure to O3. The synthetic O3-derived oxysterol Seco A has
previously been described as a highly reactive ozonolysis prod-
uct capable of adducting with the lysine amino acid residues on
various proteins (29). Throughout our study, we determined
that O3-derived oxysterols, including Seco A, can effectively
form adducts with proteins LXR-, LXR-, and PPAR-, which
all regulate lipidmetabolism (40, 41). Additionally, supplemen-
tationwith alkynyl-tagged cholesterol reveals that in the human
airway exposure to O3 generates reactive oxysterols capable of
forming adducts with the LXR- and HSP90 proteins. The
comparatively diffuse band observed in Fig. 7D and quantita-
FIGURE 5. IL6 expression and production in the lung of O3-exposed LXR-deficient mice. Wild type (WT) and LXR-
/ female mice were exposed to
filtered air (Air) or 2 ppm O3 for 3 h. Mice were necropsied 6 h after start of exposure. A, bronchoalveolar lavage was collected and evaluated for IL6 cytokine
concentrations by ELISA. B, after necropsy, lung tissues were collected for RNA isolation and evaluated for gene expression of IL6 and 18S. Bronchoalveolar
lavagewas also evaluated for total Seco A (C), total Seco B (D), and total cholesterol (E). Datawere presented asmeans S.E. Statistical analysis was performed
with Mann-Whitney test comparing LXR-/ to WT, *, p 0.05, n 5 animals per group.
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tively analyzed in Fig. 7E is most likely indicative of a heteroge-
neous mixture of O3-derived oxysterols being formed that can
adduct LXR and of a variety of post-translational modifications
to LXR- in addition to a-Seco A adduction resulting in a
mixture of proteins recognizable by the anti-LXR- antibody.
Hence, data presented here reveal a novel biochemical mecha-
nism involving the conversion of cellular cholesterol by O3 into
reactive oxysterol species, a process that results in the adduc-
tion of key proteins and modification of cellular signaling.
The formation of adducts between O3-derived oxysterols
and LXR provides a model signaling mechanism, which results
inmodifications of airway inflammatory and cholesterol home-
ostasis signaling. Endogenous oxysterols are known to be
formed during normal cholesterol regulation and metabolism.
These compounds play a role in normal LXR activation, pro-
moting cholesterol homeostasis. Mouse model systems with
LXR and cholesterol efflux deficiencies have higher cholesterol
accumulation, potentiated atherosclerosis, and are more sus-
ceptible to systemic infection (42). These effects occur partially
via the endogenous oxysterol-induced activation of LXR and
transcriptional activation of genes such asABCA1, whichmedi-
ate cholesterol shuttling and ultimately packaging into HDL
(43, 44). In contrast, our data show that in human bronchial
epithelial cells, O3 exposure decreases the expression of
ABCA1, suggesting that O3 or its oxidation products have an
inhibitory effect on the transcriptional activation of ABCA1.
Decreased ABCA1 expression and subsequent decreased cho-
lesterol efflux may result in accumulation of intracellular cho-
lesterol leading to dyslipidemia and propagation of respiratory,
metabolic, and cardiovascular health problems (13, 45).
Whether the observations related toO3-induced suppression of
ABCA1 expression affect systemic cholesterol metabolism and
potentially contribute to the enhanced atherosclerosis and car-
diovascular events associated with O3 exposure remain to be
established. In addition to cholesterol homeostasis, previous
studies have indicated that normal LXR activation is necessary
for immune health. LXR activation by synthetic agonists leads
to decreased neutrophil recruitment and increased bacterial
burden, indicating that LXR activation balance contributes to
host immune defense (46). Recent studies also suggest that LXR
agonists show therapeutic promise in treating lung disorders
such as dyslipidemia and asthma (43, 47, 48). Furthermore,
our data show that O3 exposure of LXR/ mice results in
enhanced pro-inflammatory response, indicating the impor-
tance of normal LXR activity to regulate O3-induced inflam-
mation (Fig. 5,A andB). The enhanced concentration ofO3-de-
rived oxysterols in the bronchoalveolar lavage sampled from
the LXR/ mice further link airway cholesterol ozonolysis
andLXR activity. It is interesting that overall cholesterol levels
were reduced in these mice exposed to O3, a change we did not
FIGURE6.Simplified stepsofprotein catchandphoto-releaseusinga-SecoAprobe in16HBEcells. Supplementationwitha-SecoA (20M) in 16HBE cells
for 4 h at 37 °C followed by cell lysis and click reaction to introduce biotin for immunoaffinity purification. A single aliquot was taken to probe the extent of
alkyne labeling via biotin-streptavidin interaction. The rest of the clicked cells were immobilized onto streptavidin beads to catch only adducted proteins and
remove un-adducted proteins. Subsequent photo-release permitted us to collect adducted proteins. A, IRDye 800CW streptavidin visualization exhibits the
extent of protein labeling with a-Seco A. B, SDS-polyacrylamide gel of photo-released proteins. An equal amount of total protein was loaded. The a-Seco
A-treated cells (right 2 lanes) exhibited significant protein adduction compared with the input lanes (left 2 lanes). C, selective antibody analyses indicate
adduction onHSP90, LXR-, LXR-, and PPAR- proteins. Anti-actin of the input lane provides another confirmation of equal loading. Representative blots are
from three separate experiments (n 3).
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observe in our human subjects. Taken together, LXR dysfunc-
tion caused by O3-derived oxysterols may contribute to
enhanced respiratory inflammation and adverse cardiovascular
health effects in humans exposed to O3.
Based on our observation of adduct formation between
O3-derived oxysterols and LXR, we hypothesize that electro-
philic O3-induced oxysterols and their derived lipid protein
adducts inhibit cholesterol signaling pathways that are nor-
mally activated by endogenous oxysterols. Our data in Fig. 8E
show that O3-derived oxysterols alone are not themselves
potent activators of LXR but that treatment with Seco A prior
to activation of LXR by the agonist T09 reduces T09-induced
LXRE activation as well as expression of ABCA1, FASN, and
SREBP1. These data suggest that Seco A-induced adduct for-
mation with LXR may prevent its activation with known ago-
nists, such as T09, or endogenous oxysterols, such as 27-hy-
droxycholesterol (49). Our previous studies have demonstrated
that Seco A readily adducts to nucleophilic lysine amino acid
residues in human serum albumin and other proteins, and we
hypothesize a similar binding site in LXR (29). LXR contains
eight lysines in a ligand binding domain (amino acids 215–434)
that are capable of binding both oxysterol and T09 ligands (14).
Based on our results, we propose that O3-derived oxysterols
block T09-mediated LXR activation either by non-competitive
FIGURE7.Protein adduct formation is observable in20Ma-Chol-supplemented16HBEcells exposed toO3. Followinga-Chol supplementation (20M),
apical medium was removed, and the cells were exposed to clean air or 0.4 ppm O3 for 4 h. Cells were harvested after 1 h of postincubation. A, lipids were
extracted as described in experiment. LC-selected reactionmonitoring profile demonstrates that a-cholesterol was incorporated into the cells and generated
ozone-derived oxysterols as those of endogenous cholesterol. B, schematic depicting a-Chol supplementation prior to O3 exposure. C, cells harvested in lysis
buffer containing inhibitors were clicked with azido-biotin. IRDye 800CW streptavidin probe displays significant extent of protein adduction upon O3-ex-
posed cells, whereas the background levels of adduction with air-exposed cells were observed. Anti-actin is served as a loading control. D, HSP90 and LXR-
Westernblots of click andphoto-releasedproteins. 16HBE cell lysateswere loaded as a positive control. E, relative densitometry analysis of LXR-protein levels
from three separate immunoblots (n 3).
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binding to the same site or by modifying the LXR structure to
inhibit normal ligand binding. Additional studies are necessary
to clarify the nucleophilic peptide site of O3-derived oxysterol
LXR adduct formation.
In contrast to expression of ABCA1, expression of IL6 and
IL8 aswell as activation ofNF-Bwere enhanced by exposure to
SecoA andotherO3-derived oxysterols.O3 is known to activate
NF-B leading to increased transcription of inflammatory cyto-
kines such as IL6 and IL8 (31, 50, 51). Similarly, other lipid
ozonization products have been shown to activate IL6 and IL8
in human airway epithelial cells (9). Our study shows that
O3-derived oxysterols enhance activation of NF-B and poten-
tiate the transcription of IL6 and IL8. LXR signaling has been
shown previously to have an inhibitory effect on NF-B and
inflammatory signaling in epithelial cells (52, 53), making it a
reasonable target for O3-derived oxysterol-induced modifica-
tion of inflammatory signaling. All the O3-derived oxysterol
species we tested increased NF-B activity, revealing that in
their presence airway epithelial cells may experience increased
inflammatory signaling leading to adverse health effects. In the
FIGURE 8. Seco A-altered cholesterol efflux pump gene expression when treated with Seco A and the T09 LXR agonist in sequence. A, experimental
design depicting how 16HBE cells were challenged for 2 h to 20M Seco A, 10M T09, or DMSO control for first challenge; media were removed and followed
by 2 h of second challenge. Samples were evaluated for ABCA1 (B), FASN (C), and SREBP1 (D) gene expression. LXRE activity wasmeasured in relative luciferase
units (RLU) compared with the respective vehicle control in the individual oxysterol challenges at 20M for 4 h (E) and sequential treatment in 16HBE cells (F).
Data are presented asmean S.E. of fold change comparedwith theDMSOcontrol. Statistical analysiswas performedwith a one-wayANOVAandFisher’s LSD
post hoc comparison test, * significantly different from the DMSO control; & significantly different from the indicated conditions, p 0.05, n 3.
FIGURE9.Oxysterol altered inflammatory signaling. IL6 (A) and IL8 (B) geneexpression in sequential challengeof 2hwith first challenge followedbyanother
2 h of second challenge on 16HBE cells exposed to 20 M of Seco A, 10 M T09, or DMSO control on collagen-coated plates. C, relative light units of NF-B
promoter reporter activity in 16HBE cells exposed to 20M of various oxysterols, 20 ng/ml TNF-, or DMSOnegative control for 4 h on collagen-coated plastic.
Data arepresented asmean S.E. of fold-change comparedwith theDMSOcontrol. Statistical analysiswasperformedwith aone-wayANOVAandFisher’s LSD
post hoc comparison test, *, p 0.05, n 3.
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experiments using sequential stimulation with Seco A and T09,
stimulation with Seco A alone, regardless of the secondary
stimulus, increases IL6 and IL8 expression, indicating that
O3-derived oxysterols potentiate the transcription of pro-in-
flammatory cytokines. In addition to directly activating the
NF-B pathway, we hypothesize that this effect may be linked
to inactivation of LXR. Activation of LXR induces a number of
anti-inflammatory responses, marked by inhibition of NF-B
activity and decreased production of pro-inflammatory media-
tors (54). Previous rodent studies show the use of LXR agonists
to inhibit NF-B activation to reduce lung injury and inflam-
mation after hemorrhage and resuscitation (55). In this role,
LXR is not recruited to LXR response elements in genes related
to lipid metabolism, but it does participate in a transrepression
mechanism of NF-B, resulting in inhibition of inflammatory
genes such as IL6 (42, 56, 57). LXR activity is controlled by a
post-translational SUMOylation modification and interaction
with nuclear receptor co-repressors, reducing NF-B activity
(58–60). The proposed SUMOylation occurs at the lysine res-
idues of LXR ensuring retinoid X receptor dimerization and
nuclear translocation (60). Thus, lipid-adduct formation at or
near these lysine residues may prevent SUMOylation of LXR,
interaction with co-repressors, and consequently activation of
NF-B. This proposed signaling mechanism provides a link
between our observed O3-derived oxysterol-induced changes
to LXR signaling and amodel forO3-inducedNF-B activation.
To enhance our understanding ofO3-induced cardiovascular
events and atherosclerosis, the biochemical mechanisms
involving O3-derived oxysterols, adduct formation with LXR,
and reduced ABCA1 expression that are reflected in systemic
changes need to be examined. Interestingly, epidemiological
studies repeatedly demonstrate the beneficial effects of choles-
terol-modifying drugs, such as statins, on air pollutant-induced
adverse health effects (61–65). Yet the mechanisms mediating
these effects are unknown and have often been ascribed to the
anti-inflammatory effects of statins. The findings presented in
this study provide an additional explanation for the beneficial
effects of statins on the response to inhaled O3. Therapeutic
treatment with lipid-targeting agents such as statins may
reduce cholesterol availability in the airways, thus reducing
oxysterol formation, and lead to changes in O3-induced
inflammation.
Collectively, our results suggest that reactive oxysterols
formed in the airways following O3 exposure interact with the
LXR signaling pathway, alter expression of genes that regulate
cholesterol efflux, fatty acid synthesis, and cholesterol regula-
tion, and enhance pro-inflammatory signaling pathways known
to be associated with O3 exposure. Our findings indicate that
cholesterol availability is paramount to the formation ofO3-de-
rived oxysterols in the airway and may provide a novel thera-
peutic target to reduce the adverse effects associatedwith ambi-
ent O3 exposure. In addition to LXR examined here, other
proteins are also likely targets for adduction byO3-derived oxy-
sterols and warrant future study into their implications in
O3-induced airway inflammation. Together, our data describe a
novel mechanistic concept linking O3 reactions with choles-
terol moieties in the human airway and its impact on health
outcomes. Our data also highlight the use of samples derived
from human in vivoO3 exposure as well as primary HBECs and
16HBE cells to provide clinical and biological relevance for
O3-derived oxysterol and their role in O3-induced inflamma-
tion in the human airway.
Experimental Procedures
Reagents—Alkynyl probes were synthesized following the
procedures published elsewhere (29, 32). DTT and iodoacet-
amide were purchased from Sigma. Streptavidin beads were
purchased from GE Healthcare. The following reagents were
purchased from their respective companies: 10% NuPAGE
Novex BisTris precastmini gel (Invitrogen); PVDFmembrane
and Simply Blue (Bio-Rad); IRDye 800CW streptavidin (925-
32230, Li-Cor, Lincoln, NE); Blocking buffer (Rockland,
Gilbertsville, PA, or Odyssey Blocking buffer, Li-Cor); and
sequencing grade trypsin (Promega V5111, Madison, WI).
Antibodies of HSP90, LXR-, PPAR-, and actin were from
Santa Cruz Biotechnology (Dallas, TX), and LXR- was pur-
chased from Abcam (Cambridge, MA).
Cell Culture—16HBE14o (16HBE) cells, an SV-40-trans-
formedhumanbronchial epithelial cell line, were a gift fromDr.
D. C. Gruenert (University of California at San Francisco).
16HBE cells were plated on fibronectin-coated (LHC Basal
Medium (Life Technologies, Inc.), 0.01% BSA (Sigma), 1% Vit-
ricol (Advanced Bio Matrix, San Diego), and 1% human
fibronectin (BD Biosciences)) 0.4-m Transwell plates
(Costar, Corning, NY) and grown submerged inminimal essen-
tial media (Gibco) with 10% FBS, 1% penicillin-streptomycin,
and 1% L-glutamine (Life Technologies, Inc.) until confluent for
6 days and 1 day at air-liquid interface before use. Primary
HBECs were obtained from healthy donors in collaboration
with the Environmental Protection Agency (EPA) using a pro-
tocol approved by the University of North Carolina at Chapel
Hill Institutional Review Board (Chapel Hill, NC), as described
previously (66) The HBECs were cultured in PneumaCult
medium for 21 days to differentiate according to previously
described methods (67, 68).
In Vitro O3 Exposure—Cultures at the air-liquid interface
were exposed to filtered air or 0.4 ppm O3 for 4 h in exposure
chambers operated by the United States EPA, as described pre-
viously (69). The dose was selected formaximal innate immune
response to O3 with minimal cytotoxicity and has been used
previously by our group (68). At 1 or 24 h after exposure, apical
sides of all cultures werewashedwith 100l of Hanks’ balanced
salt solution (HBSS) (Life Technologies, Inc.) and saved for
LC-MS analysis. The remaining cells were collected in 200l of
PBS, centrifuged at 500 g for 5min, and stored at80 °Cuntil
LC-MS analysis.
In Vivo Exposure of Healthy Volunteers to O3—Written
informed consent was provided by each participant. Healthy
volunteers were randomly exposed to air and (in a separate
exposure) 0.3 ppm O3 for 2 h with exercise, with a minimum
2-week separation between exposures in collaboration with the
EPA using a protocol approved by the University of North Car-
olina Chapel Hill Institutional Review Board, as described pre-
viously (70). Bronchoscopy was performed 1 and 24 h after
exposure. Cell-free BALF was stored at80 °C pending analy-
sis (30).
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Real Time qPCR—Total RNA was isolated from 16HBEs and
HBECs with the use of the Pure Link RNAmini kit (Life Tech-
nologies, Inc.). First strand cDNA preparation and real time
qPCR were performed as described previously (71, 72). The
following primers and probes for ABCA1, ABCG1, FASN,
SREBP1, and ACTBwere commercially available (Applied Bio-
systems, Foster City, CA) and were prepared in-house: human
IL8, 5-FAM-CCTTGGCAAAACTGCACCTTCAC-TAMR-
A-3 (probe), 5-TTGGCAGCCTTCCTGATTTC-3 (sense),
and 5-TATGCACTGACATCTAAGTTCTTTAGCA-3
(antisense); and IL6, 5-FAM-CCAGCATCAGTCCCAAGAA-
GGCAACT-TAMRA-3 (probe), 5-TATGAAGTTCCTCTC-
TGCAAGAGA-3 (sense), and 5-TAGGGAAGGCCGTG-
GTT-3 (antisense). Differences in expressionwere determined
with the 		Ct method and ACTB for normalization. Briefly,
threshold cycle (Ct) value for the housekeeping gene ACTB)
was subtracted from the Ct value for the gene of interest to
determine the	Ct value. For each pairwise set of samples to be
compared, the difference in 	Ct values between the two sam-
ples were calculated for the genes of interest to determine the
	Ct value. The fold-change in gene expression was calculated
as 2		Ct.
Sterol Profiling Using PTAD Derivatization and LC-selected
Reaction Monitoring Analysis—Cells were scraped into 400 l
of cold PBS. 200 l of the 400 l were taken and internal stan-
dards added (13 ng for d7-7-dehydroxycholesterol (d7-7-DHC),
97 ng for 13C3-desmosterol, 99 ng for 13C3-lanosterol, and 342
ng for d7-cholesterol/sample), 10 l of butylated hydroxytolu-
ene (BHT)/triphenylphosphine (TPP) solution (2.5 mg of TPP
and 1mg of BHT in 1ml ofMeOH), 400l of 1%NaCl, and 500
l of Folch solution (2:1CHCl3/MeOH). Cells and standards
were vortexed vigorously and centrifuged at 3099 g for 5min.
CHCl3 layer was removed and added to PTAD-predeposited
tube (200 g/tube). The sample tubes were vortexed and ana-
lyzed by LC-MS using the following conditions: 10 l was
injected onto the column (Acquity UPLC BEH C18, 1.7 m,
2.1 50mm)with 100%MeOH (0.1% acetic acid)mobile phase
for a 1min runtime at a flow rate of 300l/min. Themonitored
transitions included 7-DHC m/z 560 3 365, d7-7-DHC m/z
567 3 372, desmosterol m/z 592 3 365, 13C3-desmosterol
m/z 5953 368, lanosterolm/z 6343 602, 13C3-lanosterolm/z
637 3 605 with retention times of 0.8, 0.5, and 0.6 min,
respectively.
Oxysterol Extraction from 16HBE or HBECCells—To the cell
pellets 10l of a-Chol (25 ng/l), 500l ofNaCl (0.9%), 10l of
TPP and BHT (25 mg of TPP and 10 mg of BHT in 10 ml of
MeOH), and 1ml of Folch solution (2:1CHCl3/MeOH)were
added. The mixture was mixed vigorously by vortex for 2 min
and separated by centrifugation with 2300  g for 3 min. The
collected organic layer (bottom layer) was evaporated to dry-
ness in a SpeedVacTM concentrator and resuspended in 100 l
of MeOH for LC-MS analysis.
Oxysterol Extraction from Cell-free BALF—To 1 ml of BALF
10 l of alkynyl-Seco B (a-Seco B) (50 ng/l), 1 ml of NaCl
(0.9%), 10l of TPP and BHT (25mg of TPP and 10mg of BHT
in 10ml ofMeOH), 2 ml ofMeOH, and 3ml of iso-octane were
added. Themixture was vortexed vigorously for 2 min and sep-
arated by centrifugation. The collected organic layer was evap-
orated to dryness in a SpeedVacTM concentrator and resus-
pended in 100 l of MeOH for LC-MS analysis.
LC-MSAnalysis—The resuspended samples were chromato-
graphed by reverse phase-HPLC using a UPLC BEH C18 col-
umn (1.7 m, 2.1 100 mm) inWaters Acquity UPLC system
equipped with an autosampler (Waters, Milford, MA) and
either electrospray ionization or atmospheric pressure chemi-
cal ionization in positive ionmode. For electrospray ionization,
the oxysterols were separated by 95% solvent B in an isocratic
method with a flow rate of 200 l/min, and the mobile phase
solvents consisted of 2 mMNH4OAc (solvent A) in water and 2
mM NH4OAc in MeOH (solvent B). The injection volume was
10 l using a partial loop with needle overfill mode. MS detec-
tions were done using a TSQ Quantum Ultra tandem mass
spectrometer (ThermoFisher, Waltham, MA), and data were
acquired and analyzed using aThermoXcaliburTM 2.2 software
package. The cholesterol and oxysterols form [MNH4] ions
in positive ion mode (10). The transitions monitored werem/z
4363 383 for Seco A/B, m/z 4183 365 for a-Seco A/B, m/z
4043 369 for Chol,m/z 3863 351 for a-Chol,m/z 4203 385
for / EpCh, and m/z 4023 367 for / a-EpCh. For atmo-
spheric pressure chemical ionization, 95%MeOH in H2O con-
taining 0.01% acetic acid was used as a mobile phase. The cho-
lesterol and oxysterols form [M  H] ions in positive ion
mode. The transitionswerem/z 3693 369 forChol,m/z 3833
383 for Seco A/B, m/z 3513 351 for a-Chol, and m/z 3853
385 for / EpCh. The transitions of cholesterol and choles-
terol esters were m/z 3653 365 monitored by HPLC-MS fol-
lowing the method described elsewhere (73). The amount of
the cholesterol esters were found to be less than 2% of free
cholesterol in the cells studied.
Cytokine Analysis—Concentration of IL6 and IL8 in the api-
cal wash of 16HBE cells exposed to O3 was determined by
enzyme-linked immunosorbent assay (ELISA) according to the
manufacturer’s instructions (BD Biosciences).
Western Blotting—Cell lysates from 16HBE cells exposed to
air/O3 or O3-derived oxysterols were separated by 10% SDS-
PAGE and transferred to nitrocellulose. Proteins were detected
using specific antibodies (SantaCruzBiotechnology) toABCA1
(1:500) or -actin (1–2000), which served as a loading control.
Antigen-antibody complexes were incubated with horseradish
peroxidase-conjugated secondary antibody and were detected
using chemiluminescence.
Murine Whole Body O3 Exposure, BAL, Cytokine and RNA
Analysis—C57BL/6J (WT) female mice, 8–12 weeks old and
weighing 15–20 g, were purchased from The Jackson Labora-
tory (Bar Harbor, ME). LXR/ female mice, 8–12 weeks old
and weighing 15–20 g, originally a kind gift from Dr. David
Mangelsdorf, were bred in-house and backcrossed
8 genera-
tions onto a C57BL/6 background before use. All experiments
were performed in accordance with the Animal Welfare Act
and the United States Public Health Service Policy on Humane
Care andUse of Laboratory Animals after review by the Animal
Care and Use Committee of the NIEHS, National Institutes of
Health.Micewere placed in stainless steel wire exposure cham-
bers inside a Plexiglas chamber and exposed to filtered air orO3
for 3 h at a dose of 2 ppm. O3 was generated by directing 100%
oxygen through an ultraviolet light generator and mixed with
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a humidified air supply to the chamber. Temperature and
humidity of chamber air were monitored continuously, as was
the O3 concentration with a Teledyne T400 ultraviolet light
photometer. BALF was collected immediately following sacri-
fice, and cell counts were performed as described previously
(74). Protein analysis was performed using BCA protein assay
(Pierce). Cytokine analysis was performed using a Bioplex assay
for IL6 on the BALF (Bio-Rad). After necropsy, lung tissue sam-
ples were snap-frozen in liquid nitrogen and stored at 80 °C
until RNA isolation. RNAwas extracted and cDNA transcribed
(Applied Biosystems, Foster City, CA). 50 ng of cDNAwas used
for qPCR for IL6 (Mm00446190_m1; Applied Biosystems) and
endogenous 18S (4319413) (Applied Biosystems). Ct values
were determined using ABI 7500 Real Time PCR System with
SDS software version 1.3.1. Change in expression was calcu-
lated using the 2		Ct method normalized to 18S expression
and expressed as fold-change comparedwith the control group.
Cell Culture and Whole Cell Labeling with a-Seco A in
16HBE—16HBE cells were plated 2 106 in 10-cm plates using
the conditions described above and then allowed to settle and
grow for 24 h. The cells were then incubated in the presence of
a-Seco A (20 M) in reduced FBS (2%)MEM for 4 h. Cells were
harvested in lysis buffer (50 mM HEPES, 150 mM NaCl, 0.1%
Triton X-100, pH 7.0) containing protease inhibitors (Sigma
P8340) on ice. The lysate was cleared by centrifugation at
10,000 g for 10min at 4 °C to remove cellular debris. The total
protein concentration was determined using standard BCA
assay (Pierce, ThermoFisher) for further click reaction.
Cell Culture andWhole Cell Labeling with a-Cholesterol Fol-
lowed by Ozone Exposure in Human Bronchial Epithelial Cells
(16HBE)—16HBE cells were grown in 24-mm transwells sub-
merged inMEMwith reduced FBS containing 20M a-Chol for
6 days. The apical media were removed 24 h before exposure.
Next, the platewas exposed to filtered air orO3 (0.4 ppm) for 4 h
and allowed to continue for an additional 1 h of incubation
without O3 (1 h postincubation). Cells were harvested in 300l
of lysis buffer/well on ice, and all wells were then combined for
each condition. The lysate was cleared by centrifugation at
10,000 g for 10min at 4 °C to remove cellular debris. The total
protein concentration was determined using standard BCA
assay (Pierce, ThermoFisher) for further click reaction.
Click Biotinylation of a-Seco A/a-Oxysterols Adducted Pro-
teins in 16HBE and Streptavidin Affinity Purification—1 ml of
cell lysates (2 mg/ml) was reduced with sodium borohydride, 5
mM final concentration, for 1 h on ice to stabilize the adducts.
Excess sodium borohydride was deactivated by acidification of
the mixture by adding 1 M HCl. Subsequently, all click reagents
were added to the reduced cell lysates, including the photo-
cleavable azido-biotin (39) (0.2 mM final concentration, tris(3-
hydroxypropyltriazoylmethyl)amine (75) (0.2 mM), CuSO4 (1
mM), and sodium ascorbate (1 mM)), and the reaction mixture
was vortexed and allowed to react at room temperature for 1 h.
50 l of the reaction mixture was saved for streptavidin visual-
ization. The rest was precipitated using cold methanol (3:1 
MeOH/H2O, v/v) to remove excess biotin linker. The precipi-
tated protein pellets were reconstituted in 1 ml of 0.1% SDS in
PBS, including 200 l of streptavidin (GE Healthcare) slurry.
The slurry was rotated in the dark for 2 h at room temperature
to capture the adducted proteins. After 2 h, the tubewas spun at
95  g for 1 min, and the supernatant was removed (flow-
through). The beads were then washed with 1 ml of 1% SDS
(two times), 4 M urea (two times), and 1 MNaCl (two times, and
25 mM ammonium bicarbonate (AMBIC, two times), respec-
tively. The slurry was transferred to a 0.2-m cellulose acetate
spin filter (Costar) in 500l of 25mMAMBIC and spun at 95
g for 1 min. The slurry was resuspended with AMBIC and
photolyzed under hand-held UV light (365 nm) for 2 h with
gentle stirring at room temperature. The spin filter was spun
at 95  g for 1 min to recover photo-released proteins. The
beads were washed twice with 500 l of 25 mM AMBIC, and
the combined filtrates were evaporated to dryness in a
SpeedVacTM concentrator.
Visualization of Biotinylated Proteins Adducted with a-Seco
A/a-Oxysterols—The saved 50 l of click reaction mixture was
mixed with SDS sample loading buffer and resolved using 10%
NuPAGE Novex BisTris gel (Invitrogen). The proteins were
electrophoretically transferred to a polyvinylidene difluoride
(PVDF) membrane (Bio-Rad) and probed with IRDye 800CW
streptavidin (Li-Cor). The extent of adduction was visualized
using Odyssey Infrared Imaging SystemTM.
Immunoblotting Analysis of Photo-released Proteins—The
photo-released and dried proteins were reconstituted in 70 l
of PBS, 25l of LDS buffer, and 5l of 1 MDTT and resolved by
10% NuPAGE Novex BisTris gel and then transferred to
PVDF membrane. The transferred proteins were incubated
with antibodies of HSP90 (anti-rabbit, Santa Cruz Biotechnol-
ogy), LXR- (anti-rabbit, Abcam), LXR- (anti-rabbit, Santa
Cruz Biotechnology), or PPAR- (anti-mouse, Santa Cruz Bio-
technology) (1:1000) overnight in the cold room at 4 °C. Alexa
Fluor 680-labeled secondary anti-rabbit or anti-mouse was
used to detect target proteins. Immunoreactive proteins were
visualized using Odyssey Infrared Imaging SystemTM (Li-Cor).
Modification of Gene Expression by Sequential Seco A-T09
Challenges—16HBE cells were grown submerged in MEM and
repeatedly challenged with 20M Seco A, 10MT09 or DMSO
in a crossover design. Briefly, cells were challengedwith the first
stimulus for 2 h, washed with HBSS, and challenged again with
either 20 M Seco A, 10 M T09 or DMSO for 2 h. The cells
were washed again withHBSS, and RNAwas collected for anal-
ysis as described above.
NF-B and LXRE Promoter Reporter Activity in 16HBE
Cells—16HBE cells were transduced with NF-B-luciferase
lentiviral vector at a multiplicity of infection of 5 and were cul-
tured for 7 days (76). To select for transduced cells, the cells
were cultured with hygromycin for 9 days to create a stable cell
line, which was used for subsequent reporter assays. To assess
NF-B activation, stably transduced 16HBE cells were plated
overnight and then treated with -EpCh, -EpCh, Seco A, Seco
B (all 20 M), or TNF- (20 ng/ml, Calbiochem, Billerica, MA)
for 4 and 24 h. For the LXRE promoter activity measurement,
LXRE-luciferase vector (System Biosciences Inc., San Fran-
cisco, CA) was transiently transfected into 16HBE cells and
allowed to expand for at least 1 day. The cells were then exposed
to individual oxysterols or used in the sequential challenge with
Seco A and T09 as described above. Cell lysates were harvested
and subjected to Dual-Luciferase assay (Promega, Madison,
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WI). Datawere normalized to total protein levels and expressed
as relative luciferase units.
Statistical Analysis—All in vitro data were performed in at
least three separate experiments. Data shown are means S.E.
and significance indicated as p  0.05. See figure legends for
further information on the specific statistical analysis used for
each experiment.
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